Noxopharm Limited

ASX:NOX.AX

0.11 (AUD) • At close September 18, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) AUD.

20232022202120202019201820172016
Operating Activities:
Net Income -15.056-18.667-9.347-0.272-11.223-18.284-3.046-0.705
Depreciation & Amortization 0.1550.2620.2620.2410.0620.0590.030.003
Deferred Income Tax -0.73-6.3191.146-4.572-1.434-8.1320-0.175
Stock Based Compensation 0.0120.8041.7420.3120.8999.46100.023
Change In Working Capital -0.591-5.0713.602-3.6270.535-1.3290.10.152
Accounts Receivables -0.4770.177-1.14-4.723-0.038-0.060.024-0.039
Inventory 1.146-0.8350.2080.1770.573-1.26900
Accounts Payables -1.079-4.3344.3430.7670.60.5970.017-0.106
Other Working Capital -0.181-0.0780.190.151-0.6-0.5970.0590.297
Other Non Cash Items 5.26515.259-6.255-3.221.3859.149-0.002-0.023
Operating Cash Flow -10.946-13.734-8.85-11.138-9.776-9.076-2.918-0.55
Investing Activities:
Investments In Property Plant And Equipment 000-0.003-0.006-0.312-0.079-0.02
Acquisitions Net 0000.3410.00300.0020
Purchases Of Investments 000000-0.0770
Sales Maturities Of Investments 0.12400000-0.0020
Other Investing Activites 0.12400.2250.3410.0030-0.1190
Investing Cash Flow 0.12400.2250.338-0.003-0.312-0.273-0.02
Financing Activities:
Debt Repayment -0.178-0.229-0.245-4.1120-3.80300
Common Stock Issued 01.20528.56910.2210.07515.7460.731
Common Stock Repurchased 00-1.528-0.7860-1.187-0.5120
Dividends Paid 00000000
Other Financing Activities -0.178-0.22928.32410.1820.07527.15-0.5121.096
Financing Cash Flow -0.1780.97628.32414.9910.07519.5445.4880.731
Other Information:
Effect Of Forex Changes On Cash -0.001-0.027-0.00400000
Net Change In Cash -11.002-12.78519.6964.191-9.70410.1562.2970.161
Cash At End Of Period 3.00914.01126.7967.12.9112.6142.4580.161